查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1635901

2025-2033 年按产品类型、活性成分、最终用户和地区分類的睾酮替代疗法市场报告

Testosterone Replacement Therapy Market Report by Product Type, Active Ingredients, End User, and Region 2025-2033
出版日期: | 出版商: IMARC | 英文 125 Pages | 商品交期: 2-3个工作天内

价格

2024年，全球睪固酮替代疗法市场规模达到20.3IMARC Group美元。大众性腺功能减退症盛行率不断上升，新配方、给药方法和治疗方案的不断开发，以及全球医疗基础设施的持续改进是推动市场的一些主要因素。

睪固酮替代疗法 (TRT) 是一种旨在解决个人（尤其是男性）睪固酮水平低下问题的医疗方法。睪酮是一种主要负责男性性特征的发育和维持以及整体健康的荷尔蒙。 TRT涉及施用外源性睪固酮来补充身体的自然产生，旨在将睪固酮水平恢復到正常范围内。低睪酮水平会导致各种症状，包括性慾降低、疲劳、肌肉损失、情绪变化和骨密度降低。 TRT 可以缓解睪酮缺乏症患者的这些症状并改善其整体生活品质。此疗法可透过多种方法进行，包括注射、贴片、凝胶或植入皮下的颗粒。

性腺功能减退症盛行率的上升正在推动全球市场的发展。此外，配方和递送方法的不断进步，包括更新的递送方法，如透皮贴片、凝胶、皮下植入物和口腔系统，提供了更高的便利性和功效，提高了患者的依从性和满意度，从而推动了市场的发展。此外，文化接受度、耻辱感的减少以及对 TRT 益处的更广泛理解也促进了市场的成长。此外，各种製药公司正在投资开发新的配方、给药方法和改进的治疗方案，这推动了市场的成长。除此之外，在医疗基础设施不断完善、医疗服务可近性提高以及可支配收入增加等因素的推动下，医疗支出的整体成长促进了TRT市场的扩张。

睾酮替代疗法市场趋势/驱动因素：

人口老化和睪固酮缺乏症的盛行率日益增加

人口老化是睾酮替代疗法（TRT）的重要市场驱动力。随着男性年龄的增长，他们的天然睪固酮生成量往往会下降，从而导致与睪固酮缺乏相关的症状。随着全球人口老化，睪固酮缺乏症的盛行率越来越高。同时，人们对 TRT 的症状和益处的认识不断增强，这增加了对睪固酮替代产品和服务的需求。此外，医疗保健提供者发现越来越多的老年患者寻求睪固酮水平低下的治疗以缓解症状，例如精力不足、性功能下降和肌肉损失，从而推动 TRT 市场的成长。

对睪酮缺乏症的认识和诊断不断提高

近年来，人们对睾酮缺乏症的认识和诊断显着增加。医疗保健专业人员对低睪酮水平的症状和影响越来越了解，从而改善检测和诊断。此外，製药公司和医疗保健组织的教育活动和行销工作也有助于提高大众对 TRT 等治疗方案可用性的认识。这些措施强调了 TRT 在解决与睪固酮缺乏相关的身体和心理症状方面的潜在益处。因此，越来越多的人寻求医疗建议并接受诊断，导致 TRT 的患者群体更大。这种认识和诊断的提高导致了睾酮替代疗法市场的扩大。

越来越关注男性健康

人们越来越重视男性的健康和保健，包括身体、心理和性福祉。男性变得更加积极主动地寻求解决与年龄相关的问题，包括睪固酮缺乏。随着社会态度转向消除男性健康问题的污名化，个人更愿意讨论和寻求与睪固酮失衡相关的疾病的治疗。这种文化转变，加上透过网路和社群媒体获取医疗资讯的机会增加，导致对 TRT 的需求更大。市场上越来越多的男性积极寻求治疗方法来解决睪固酮缺乏问题并提高整体生活品质。此外，不断扩大的健康产业和男性医疗保健整体方法的整合进一步刺激了对 TRT 的需求。

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 数据来源
    • 主要来源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球睪酮替代疗法市场

  • 市场概况
  • 市场表现
  • COVID-19 的影响
  • 市场预测

第 6 章：市场区隔：依产品类型

  • 口腔植体
    • 市场趋势
    • 市场预测
  • 注射
    • 市场趋势
    • 市场预测
  • 补丁
    • 市场趋势
    • 市场预测
  • 乳霜/凝胶
    • 市场趋势
    • 市场预测
  • 牙龈/颊黏胶
    • 市场趋势
    • 市场预测
  • 其他的
    • 市场趋势
    • 市场预测

第 7 章：市场区隔：依活性成分

  • 睪固酮
    • 市场趋势
    • 市场预测
  • 甲基睪酮
    • 市场趋势
    • 市场预测
  • 环丙酸睪酮
    • 市场趋势
    • 市场预测
  • 十一酸睪酮
    • 市场趋势
    • 市场预测
  • 庚酸睪酮
    • 市场趋势
    • 市场预测

第 8 章：市场区隔：依最终用户

  • 医院
    • 市场趋势
    • 市场预测
  • 居家护理
    • 市场趋势
    • 市场预测
  • 专科诊所
    • 市场趋势
    • 市场预测
  • 其他的
    • 市场趋势
    • 市场预测

第 9 章：市场区隔：按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 市场趋势
    • 市场细分：按国家/地区
    • 市场预测

第 10 章：驱动因素、限制与机会

  • 概述
  • 司机
  • 限制
  • 机会

第 11 章：价值链分析

第 12 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 13 章：价格分析

第14章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • AbbVie Inc.
    • Acerus Pharmaceuticals Corporation
    • Antares Pharma Inc. (Halozyme Therapeutics)
    • Clarus Therapeutics Inc.
    • Endo International plc
    • Ferring Pharmaceuticals
    • Kyowa Kirin Co. Ltd.
    • Lupin Limited
    • Pfizer Inc.
    • Sun Pharmaceutical Industries Ltd.
    • Teva Pharmaceuticals USA Inc. (Teva Pharmaceutical Industries Ltd.)
    • Upsher-Smith Laboratories LLC (Sawai Pharmaceutical Co. Ltd.)
Product Code: SR112025A6832

The global testosterone replacement therapy market size reached USD 2.03 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 2.73 Billion by 2033, exhibiting a growth rate (CAGR) of 3.2% during 2025-2033. The rising prevalence of hypogonadism among the masses, continual development of new formulations, delivery methods, and improved treatment protocols, and ongoing improvements in healthcare infrastructure across the globe are some of the major factors propelling the market.

Testosterone replacement therapy (TRT) is a medical treatment designed to address low testosterone levels in individuals, particularly men. Testosterone is a hormone primarily responsible for the development and maintenance of male sexual characteristics and overall well-being. TRT involves the administration of exogenous testosterone to supplement the body's natural production, aiming to restore testosterone levels within the normal range. Low testosterone levels can result in various symptoms, including reduced libido, fatigue, muscle loss, mood changes, and decreased bone density. TRT can alleviate these symptoms and improve the overall quality of life for individuals experiencing testosterone deficiency. The therapy can be administered through various methods, including injections, patches, gels, or pellets implanted under the skin.

The rising prevalence of hypogonadism is driving the global market. Moreover, continual advancements in the formulation and delivery methods, including newer delivery methods, such as transdermal patches, gels, subcutaneous implants, and buccal systems, offer improved convenience and efficacy, enhancing patient compliance and satisfaction is providing a boost to the market. Furthermore, cultural acceptance, reduced stigma, and a broader understanding of the benefits of TRT have contributed to the growth of the market. Also, various pharmaceutical companies are investing in the development of new formulations, delivery methods, and improved treatment protocols, which fuels the growth of the market. Apart from this, the overall growth in healthcare expenditure, driven by factors such as rising healthcare infrastructure, improving access to healthcare services, and increasing disposable income, has catalyzed the expansion of the TRT market.

Testosterone Replacement Therapy Market Trends/Drivers:

Aging Population and the Increasing Prevalence Of Testosterone Deficiency

The aging population is a significant market driver for testosterone replacement therapy (TRT). As men age, their natural testosterone production tends to decline, resulting in symptoms associated with testosterone deficiency. With the global population experiencing a demographic shift towards an older age bracket, there is a growing prevalence of testosterone deficiency. Coupled with this, the increasing awareness of the symptoms and benefits of TRT, is augmenting the demand for testosterone replacement products and services. Furthermore, healthcare providers are witnessing an increase in older patients seeking treatment for low testosterone levels to alleviate symptoms, such as reduced energy, diminished sexual function, and muscle loss, thereby propelling the growth of the TRT market.

Rising Awareness and Diagnosis of Testosterone Deficiency

There has been a notable increase in awareness and diagnosis of testosterone deficiency in recent years. Healthcare professionals are becoming more knowledgeable about the symptoms and effects of low testosterone levels, leading to improved detection and diagnosis. Additionally, educational campaigns and marketing efforts by pharmaceutical companies and healthcare organizations have contributed to raising public awareness about the availability of treatment options, such as TRT. These initiatives emphasize the potential benefits of TRT in addressing the physical and psychological symptoms associated with testosterone deficiency. As a result, more individuals are seeking medical advice and getting diagnosed, leading to a larger patient pool for TRT. This heightened awareness and diagnosis have resulted in an expanded market for testosterone replacement therapies.

Growing Focus on Men's Health and Wellness

There is a growing emphasis on men's health and wellness, encompassing physical, mental, and sexual well-being. Men are becoming more proactive in seeking solutions to age-related issues, including testosterone deficiency. As societal attitudes shift towards destigmatizing men's health concerns, individuals are more open to discussing and seeking treatment for conditions related to testosterone imbalance. This cultural shift, along with increased accessibility to healthcare information through the internet and social media, has contributed to a greater demand for TRT. The market is witnessing a rise in men who are actively pursuing therapies to address testosterone deficiency and improve their overall quality of life. Furthermore, the expanding wellness industry and the integration of holistic approaches in men's healthcare have further fueled the demand for TRT.

Testosterone Replacement Therapy Industry Segmentation:

Breakup by Product Type:

Oral implants

Injections

Patches

Creams/Gels

Gums/Buccal Adhesives

Others

Injections dominate the market

On the basis of product type, injections represent the largest product type segment in the testosterone replacement therapy (TRT) market. Injections are a popular and widely utilized method for delivering testosterone replacement. They offer several advantages, including reliable dosing, immediate effects, and the ability to closely monitor the administration. Injections typically involve intramuscular or subcutaneous delivery, ensuring efficient absorption of testosterone into the bloodstream. This method provides healthcare professionals with greater control over dosage and allows for adjustments based on individual patient needs. Moreover, they offer convenience as they are administered less frequently compared to other forms of TRT, such as transdermal patches or gels. This reduced frequency of administration contributes to better patient compliance. Additionally, injections are preferred in cases where patients require higher testosterone levels or have specific medical conditions that may necessitate precise dosing.

Breakup by Active Ingredients:

Testosterone

Methyl Testosterone

Testosterone Cypionate

Testosterone Undecanoate

Testosterone Enanthate

Testosterone holds the largest share in the market

Testosterone represents the largest segment in the testosterone replacement therapy (TRT) market. Testosterone is the primary hormone responsible for the development and maintenance of male sexual characteristics and overall well-being. In TRT, the goal is to supplement or replace the body's natural testosterone production, and testosterone is the most direct and commonly used active ingredient to achieve this. It is available in various formulations, including injections, transdermal patches, gels, and pellets. Moreover, it provides healthcare providers with the flexibility to tailor treatment regimens to individual patient needs. Additionally, testosterone-based products have been extensively studied and researched, providing a robust foundation of clinical evidence supporting their effectiveness in managing testosterone deficiency. Due to its central role in TRT and its proven efficacy, testosterone remains the dominant active ingredient segment in the TRT market, serving as the cornerstone for addressing testosterone imbalances and improving patients' quality of life.

Breakup by End User:

Hospitals

Homecare

Specialty Clinics

Others

Speciality Clinics hold the largest share in the market

On the basis of end user, specialty clinics represent the largest segment in the testosterone replacement therapy (TRT) market. Specialty clinics are healthcare facilities that focus on specific medical specialties or conditions, including men's health and hormone optimization. These clinics are staffed with specialized healthcare professionals, such as endocrinologists, urologists, and hormone therapy specialists, who possess in-depth knowledge and expertise in diagnosing and treating testosterone deficiency. They offer a dedicated and comprehensive approach to TRT, providing personalized care and tailored treatment plans for patients with low testosterone levels. These clinics often have the necessary resources and equipment to administer various forms of TRT, including injections, patches, gels, and pellets. Moreover, specialty clinics are equipped to conduct thorough evaluations, monitor hormone levels, and adjust treatment regimens as needed to optimize patient outcomes.

Breakup by Region:

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America exhibits a clear dominance, accounting for the largest testosterone replacement therapy market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

Region-wise, North America exhibits a clear dominance in the testosterone replacement therapy (TRT) market. The well-developed healthcare infrastructure in the region is characterized by advanced medical facilities, specialized clinics, and a strong network of healthcare providers. This infrastructure facilitates the diagnosis, treatment, and monitoring of testosterone deficiency, driving the demand for TRT. Additionally, the region has a high prevalence of testosterone deficiency, which can be attributed to factors such as an aging population, sedentary lifestyles, and increasing awareness of the symptoms and benefits of TRT. Moreover, the region is at the forefront of medical advancements and research in the field of hormone replacement therapies, leading to the availability of a wide range of TRT products and treatment options. Furthermore, robust regulatory frameworks and guidelines ensure the safety and efficacy of TRT in North America, instilling confidence in both healthcare providers and patients.

Competitive Landscape:

Companies are heavily investing in research and development activities to develop innovative TRT products and treatment options. This includes exploring new formulations, delivery systems, and technologies to enhance treatment efficacy, convenience, and patient compliance. Several leading players are conducting clinical trials to gather evidence supporting the safety and efficacy of their TRT products. These trials help validate the therapeutic benefits of their offerings and gain regulatory approvals. Moreover, companies engage in marketing and awareness campaigns to educate healthcare professionals and patients about the symptoms of testosterone deficiency and the benefits of TRT. These campaigns aim to increase awareness, reduce stigma, and drive demand for their products and services. Additionally, companies collaborate with healthcare providers, specialty clinics, and research institutions to expand their market reach, gain access to patient populations, and leverage expertise in specific therapeutic areas.

The report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

AbbVie Inc.

Acerus Pharmaceuticals Corporation

Antares Pharma Inc. (Halozyme Therapeutics)

Clarus Therapeutics Inc

Endo International plc

Ferring Pharmaceuticals

Kyowa Kirin Co. Ltd.

Lupin Limited

Pfizer Inc.

Sun Pharmaceutical Industries Ltd.

Teva Pharmaceuticals USA Inc. (Teva Pharmaceutical Industries Ltd.)

Upsher-Smith Laboratories LLC (Sawai Pharmaceutical Co. Ltd.)

Key Questions Answered in This Report:

  • How has the global testosterone replacement therapy market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global testosterone replacement therapy market?
  • What is the impact of each driver, restraint, and opportunity on the global testosterone replacement therapy market?
  • What are the key regional markets?
  • Which countries represent the most attractive testosterone replacement therapy market?
  • What is the breakup of the market based on the product type?
  • Which is the most attractive product type in the testosterone replacement therapy market?
  • What is the breakup of the market based on the active ingredients?
  • Which is the most attractive active ingredients in the testosterone replacement therapy market?
  • What is the breakup of the market based on the end user?
  • Which is the most attractive end user in the testosterone replacement therapy market?
  • What is the competitive structure of the global testosterone replacement therapy market?
  • Who are the key players/companies in the global testosterone replacement therapy market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Testosterone Replacement Therapy Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product Type

  • 6.1 Oral Implants
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Injections
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Patches
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Creams/Gels
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Gums/Buccal Adhesives
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast
  • 6.6 Others
    • 6.6.1 Market Trends
    • 6.6.2 Market Forecast

7 Market Breakup by Active Ingredients

  • 7.1 Testosterone
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Methyl Testosterone
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Testosterone Cypionate
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Testosterone Undecanoate
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Testosterone Enanthate
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Homecare
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Specialty Clinics
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Others
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 Drivers, Restraints, and Opportunities

  • 10.1 Overview
  • 10.2 Drivers
  • 10.3 Restraints
  • 10.4 Opportunities

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 AbbVie Inc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Acerus Pharmaceuticals Corporation
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 Antares Pharma Inc. (Halozyme Therapeutics)
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 SWOT Analysis
    • 14.3.4 Clarus Therapeutics Inc.
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
    • 14.3.5 Endo International plc
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 Ferring Pharmaceuticals
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
    • 14.3.7 Kyowa Kirin Co. Ltd.
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Lupin Limited
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Pfizer Inc.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Sun Pharmaceutical Industries Ltd.
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis
    • 14.3.11 Teva Pharmaceuticals USA Inc. (Teva Pharmaceutical Industries Ltd.)
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
    • 14.3.12 Upsher-Smith Laboratories LLC (Sawai Pharmaceutical Co. Ltd.)
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

List of Figures

  • Figure 1: Global: Testosterone Replacement Therapy Market: Major Drivers and Challenges
  • Figure 2: Global: Testosterone Replacement Therapy Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Testosterone Replacement Therapy Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Testosterone Replacement Therapy Market: Breakup by Product Type (in %), 2024
  • Figure 5: Global: Testosterone Replacement Therapy Market: Breakup by Active Ingredients (in %), 2024
  • Figure 6: Global: Testosterone Replacement Therapy Market: Breakup by End User (in %), 2024
  • Figure 7: Global: Testosterone Replacement Therapy Market: Breakup by Region (in %), 2024
  • Figure 8: Global: Testosterone Replacement Therapy (Oral Implants) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 9: Global: Testosterone Replacement Therapy (Oral Implants) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 10: Global: Testosterone Replacement Therapy (Injections) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: Testosterone Replacement Therapy (Injections) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: Testosterone Replacement Therapy (Patches) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: Testosterone Replacement Therapy (Patches) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: Testosterone Replacement Therapy (Creams/Gels) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: Testosterone Replacement Therapy (Creams/Gels) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: Testosterone Replacement Therapy (Gums/Buccal Adhesives) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: Testosterone Replacement Therapy (Gums/Buccal Adhesives) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: Testosterone Replacement Therapy (Other Product Types) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: Testosterone Replacement Therapy (Other Product Types) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: Testosterone Replacement Therapy (Testosterone) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: Testosterone Replacement Therapy (Testosterone) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: Global: Testosterone Replacement Therapy (Methyl Testosterone) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: Global: Testosterone Replacement Therapy (Methyl Testosterone) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: Global: Testosterone Replacement Therapy (Testosterone Cypionate) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: Global: Testosterone Replacement Therapy (Testosterone Cypionate) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: Global: Testosterone Replacement Therapy (Testosterone Undecanoate) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: Global: Testosterone Replacement Therapy (Testosterone Undecanoate) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: Global: Testosterone Replacement Therapy (Testosterone Enanthate) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: Global: Testosterone Replacement Therapy (Testosterone Enanthate) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: Global: Testosterone Replacement Therapy (Hospitals) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: Global: Testosterone Replacement Therapy (Hospitals) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: Global: Testosterone Replacement Therapy (Homecare) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: Global: Testosterone Replacement Therapy (Homecare) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: Global: Testosterone Replacement Therapy (Specialty Clinics) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: Global: Testosterone Replacement Therapy (Specialty Clinics) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: Global: Testosterone Replacement Therapy (Other End Users) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: Global: Testosterone Replacement Therapy (Other End Users) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: North America: Testosterone Replacement Therapy Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: North America: Testosterone Replacement Therapy Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: United States: Testosterone Replacement Therapy Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: United States: Testosterone Replacement Therapy Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: Canada: Testosterone Replacement Therapy Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: Canada: Testosterone Replacement Therapy Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: Asia-Pacific: Testosterone Replacement Therapy Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: Asia-Pacific: Testosterone Replacement Therapy Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: China: Testosterone Replacement Therapy Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: China: Testosterone Replacement Therapy Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: Japan: Testosterone Replacement Therapy Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: Japan: Testosterone Replacement Therapy Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: India: Testosterone Replacement Therapy Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: India: Testosterone Replacement Therapy Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: South Korea: Testosterone Replacement Therapy Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: South Korea: Testosterone Replacement Therapy Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: Australia: Testosterone Replacement Therapy Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: Australia: Testosterone Replacement Therapy Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: Indonesia: Testosterone Replacement Therapy Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: Indonesia: Testosterone Replacement Therapy Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: Others: Testosterone Replacement Therapy Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: Others: Testosterone Replacement Therapy Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: Europe: Testosterone Replacement Therapy Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: Europe: Testosterone Replacement Therapy Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: Germany: Testosterone Replacement Therapy Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: Germany: Testosterone Replacement Therapy Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: France: Testosterone Replacement Therapy Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: France: Testosterone Replacement Therapy Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: United Kingdom: Testosterone Replacement Therapy Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: United Kingdom: Testosterone Replacement Therapy Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: Italy: Testosterone Replacement Therapy Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: Italy: Testosterone Replacement Therapy Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 70: Spain: Testosterone Replacement Therapy Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 71: Spain: Testosterone Replacement Therapy Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 72: Russia: Testosterone Replacement Therapy Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 73: Russia: Testosterone Replacement Therapy Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 74: Others: Testosterone Replacement Therapy Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 75: Others: Testosterone Replacement Therapy Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 76: Latin America: Testosterone Replacement Therapy Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 77: Latin America: Testosterone Replacement Therapy Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 78: Brazil: Testosterone Replacement Therapy Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 79: Brazil: Testosterone Replacement Therapy Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 80: Mexico: Testosterone Replacement Therapy Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 81: Mexico: Testosterone Replacement Therapy Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 82: Others: Testosterone Replacement Therapy Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 83: Others: Testosterone Replacement Therapy Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 84: Middle East and Africa: Testosterone Replacement Therapy Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 85: Middle East and Africa: Testosterone Replacement Therapy Market: Breakup by Country (in %), 2024
  • Figure 86: Middle East and Africa: Testosterone Replacement Therapy Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 87: Global: Testosterone Replacement Therapy Industry: Drivers, Restraints, and Opportunities
  • Figure 88: Global: Testosterone Replacement Therapy Industry: Value Chain Analysis
  • Figure 89: Global: Testosterone Replacement Therapy Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Testosterone Replacement Therapy Market: Key Industry Highlights, 2024 & 2033
  • Table 2: Global: Testosterone Replacement Therapy Market Forecast: Breakup by Product Type (in Million USD), 2025-2033
  • Table 3: Global: Testosterone Replacement Therapy Market Forecast: Breakup by Active Ingredients (in Million USD), 2025-2033
  • Table 4: Global: Testosterone Replacement Therapy Market Forecast: Breakup by End User (in Million USD), 2025-2033
  • Table 5: Global: Testosterone Replacement Therapy Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 6: Global: Testosterone Replacement Therapy Market: Competitive Structure
  • Table 7: Global: Testosterone Replacement Therapy Market: Key Players